Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

646
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
646
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

593
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
593
Pleiotropy01:33

Pleiotropy

44.0K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

588
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
588
Neural Regulation01:37

Neural Regulation

44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Treating Post-Traumatic Epilepsy in Children With Ketogenic Diet.

Journal of child neurology·2026
Same author

Navigating new motor function trajectories: Consensus recommendations for assessment in the era of newborn screening and early treatment in SMA.

Journal of neuromuscular diseases·2026
Same author

New SMA era: A broad-range tiered assessment of function for the evolving SMA phenotype (EVOLVE-SMA).

Journal of neuromuscular diseases·2025
Same author

Vigabatrin-Associated Brain Magnetic Resonance Imaging Abnormalities in Two Children With WW domain-containing oxidoreductase-Related Epileptic Encephalopathy Syndrome.

Pediatric neurology·2025
Same author

Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study.

Therapeutic advances in rare disease·2025
Same author

Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy.

The Journal of clinical investigation·2025

Related Experiment Video

Updated: Mar 24, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.5K

Hereditary Neuropathy with Liability to Pressure Palsies.

Hyoung Won Choi1, Nancy L Kuntz1

  • 1Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Pediatric Neurology Briefs
|March 3, 2016
PubMed
Summary

This study examined hereditary neuropathy with liability to pressure palsies (HNPP) in 12 children with a PMP22 gene deletion. Researchers analyzed clinical symptoms and electrophysiological results to understand this rare genetic nerve disorder.

Keywords:
ChildhoodHNPPMononeuropathiesPMP22 Protein

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

20.9K

Related Experiment Videos

Last Updated: Mar 24, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.5K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

20.9K

Area of Science:

  • Pediatric Neurology
  • Clinical Genetics
  • Electrophysiology

Background:

  • Hereditary neuropathy with liability to pressure palsies (HNPP) is a rare genetic disorder affecting peripheral nerves.
  • PMP22 gene deletions are a known cause of HNPP, leading to nerve dysfunction.
  • Understanding the clinical and electrophysiological characteristics in children is crucial for diagnosis and management.

Purpose of the Study:

  • To analyze the clinical presentation of pediatric HNPP cases.
  • To evaluate electrophysiological data in children with HNPP caused by PMP22 gene deletion.
  • To correlate clinical findings with electrophysiological results in this specific pediatric cohort.

Main Methods:

  • Retrospective analysis of clinical data from 12 pediatric patients diagnosed with HNPP.
  • Review of electrophysiological studies (e.g., nerve conduction studies, EMG).
  • Correlation of PMP22 gene deletion status with observed clinical and electrophysiological phenotypes.

Main Results:

  • Detailed description of the clinical symptoms observed in the 12 children.
  • Presentation of key electrophysiological findings, highlighting nerve conduction abnormalities.
  • Identification of patterns in clinical presentation and electrophysiological results associated with PMP22 deletion.

Conclusions:

  • The study provides valuable insights into the presentation of HNPP in children with PMP22 gene deletions.
  • Electrophysiological data are essential for confirming the diagnosis and characterizing the severity of nerve involvement.
  • Findings contribute to a better understanding of this genetic neuropathy in a pediatric population.